The FDA has acknowledged a distinct link between breast implants and cancer. Specifically known to scientists as large cell lymphoma (ALCL), ALCL is known to be a rare form of non-Hodgkin’s lymphoma. More than 350 women have come forward to tell the FDA that they were diagnosed with ALCL after receiving breast implants. So far, this cancer of the blood has claimed the lives of 9 women.French regulators proved to be ahead of the curve in 2016 after acknowledging this life threatening link-giving the manufactures the burden of proof to prove the safety of their products.
Via Daily Mail:
“Some research has suggested bacteria on the outer shell introduced during implantation leads to immune system changes that trigger the cancer. However, this is not proven.
British body the Medicines and Healthcare Products Regulatory Agency (MHRA) has not revised its guidance since 2014. A spokesman said: ‘We will closely monitor the results of the investigation by the French Regulatory Authority and will take appropriate regulatory or safety action if needed.’
In most cases of BIA-ALCL, women are successfully treated with surgery alone, but chemotherapy and radiotherapy may also be needed.” Luckily, regulators have confirmed that ALCL can be treated by simply reliving the implants. “All of the information to date suggests that women with breast implants have a very low but increased risk of developing ALCL compared to women who do not have breast implants,’ the FDA said in a statement released on Tuesday.
‘Most cases of breast implant-associated ALCL are treated by removal of the implant and the capsule surrounding the implant and some cases have been treated by chemotherapy and radiation,’ it said.” With breast implants being the second most popular form of plastic surgery, it is important that women are mindful of all potential risks associated with the procedure.